Learn more

TARGANTA THERAPEUTICS CORP

Overview
  • Total Patents
    21
About

TARGANTA THERAPEUTICS CORP has a total of 21 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and organic fine chemistry are HIBERNATION THERAPEUTICS A KF LLC, SYMBOLLON CORP and HIBERNATION THERAPEUTICS LTD.

Patent filings per year

Chart showing TARGANTA THERAPEUTICS CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Moeck Gregory 12
#2 Lehoux Dario 11
#3 Parr Thomas R 9
#4 Beaulieu Sylvain 4
#5 Dario Lehoux 4
#6 Mckay Geoffrey 4
#7 Etienne Pierre 4
#8 Rafai Far Adel 3
#9 Baines Simon 3
#10 Wilcox Mark Harvey 3

Latest patents

Publication Filing date Title
EP2424559A1 Methods of treating bacterial infections using oritavancin
EA020490B1 Method of treatment of bacterial infection
EP2324041A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
EP2278989A2 Methods of inhibiting and treating biofilms using glycopeptide antibiotics
EA017564B1 Method of inhibiting clostridium difficile by administration of oritavancin
WO2008118784A1 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
AU2007346657A1 Use of oritavancin for prevention and treatment of anthrax